DrugPatentWatch Database Preview
Florbetapir f-18 - Generic Drug Details
What are the generic sources for florbetapir f-18 and what is the scope of freedom to operate?
Florbetapir f-18
is the generic ingredient in one branded drug marketed by Avid Radiopharms Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Florbetapir f-18 has forty-six patent family members in thirty-one countries.
One supplier is listed for this compound.
Summary for florbetapir f-18
| International Patents: | 46 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 3 |
| Clinical Trials: | 40 |
| Patent Applications: | 7 |
| DailyMed Link: | florbetapir f-18 at DailyMed |
Recent Clinical Trials for florbetapir f-18
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Neil M Rofsky, MD, MHA | Phase 2 |
| Five Eleven Pharma, Inc. | Phase 1 |
| National Institute on Aging (NIA) | Phase 3 |
Pharmacology for florbetapir f-18
| Drug Class | Radioactive Diagnostic Agent |
| Mechanism of Action | Positron Emitting Activity |
Synonyms for florbetapir f-18
| [18F]Florbetapir |
| 18F-AV-45 |
| 18F-AV45 |
| 18FAV45 |
| 4-((1E)-2-(6-{2-(2-(2-(18F)fluoroethoxy)ethoxy)ethoxy}pyridin-3-yl)ethenyl)-N- methylbenzenamine |
| 4-(2-(6-(2-(2-(2-Fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzamide |
| 4-[(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl]-N-methylaniline |
| 4-{(E)-2-[6-(2-{2-[2-((18)F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl}-N-methylaniline |
| 4-{(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl}-N-methylaniline |
| 6W15Z5R0RU |
| 956103-76-7 |
| Amyvid |
| Amyvid (TN) |
| AV-45 |
| AV-45 compound |
| Benzenamine, 4-((1E)-2-(6-(2-(2-(2-(fluoro-18F)ethoxy)ethoxy)ethoxy)-3- pyridinyl)ethenyl)-N- methyl- |
| CHEBI:66880 |
| CHEMBL1774461 |
| D09617 |
| DB09149 |
| DTXSID80241898 |
| Florbetapir |
| florbetapir (18F) |
| Florbetapir (18F) [INN] |
| Florbetapir F 18 |
| Florbetapir F-18 (USAN) |
| Florbetapir F-18 [USAN:INN] |
| florbetapir F18 |
| florbetapir-fluorine-18 |
| GTPL7344 |
| Pet AV-45 |
| SCHEMBL14826096 |
| UNII-6W15Z5R0RU |
| YNDIAUKFXKEXSV-CRYLGTRXSA-N |
US Patents and Regulatory Information for florbetapir f-18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-001 | Apr 6, 2012 | DISCN | No | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-003 | Apr 6, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-002 | Apr 6, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-002 | Apr 6, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-003 | Apr 6, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Avid Radiopharms Inc | AMYVID | florbetapir f-18 | SOLUTION;INTRAVENOUS | 202008-001 | Apr 6, 2012 | DISCN | No | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for florbetapir f-18
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2363392 | Start Trial |
| Serbia | 56171 | Start Trial |
| South Korea | 20080106564 | Start Trial |
| Norway | 342090 | Start Trial |
| South Africa | 200807955 | Start Trial |
| China | 101522624 | Start Trial |
| Austria | 539060 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for florbetapir f-18
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1999109 | 139 5017-2013 | Slovakia | Start Trial | PRODUCT NAME: FLORBETAPIR ( 18 F); REGISTRATION NO/DATE: EU/1/12/805 20130114 |
| 1999109 | C300600 | Netherlands | Start Trial | PRODUCT NAME: FLORBETAPIR ( SUP 18 /SUP F); REGISTRATION NO/DATE: EU/1/12/805 20130114 |
| 1999109 | 1390030-3 | Sweden | Start Trial | PRODUCT NAME: FLORBETAPIR (18F); REG. NO/DATE: EU/1/12/805 20130114 |
| 1999109 | C 2013 023 | Romania | Start Trial | PRODUCT NAME: FLORBETAPIR(18F)4-[(1E)-2-(6-{2-[2-(2-[18F]FLUOROETOXI)ETOXI]ETOXI}PIRIDIN-3-IL)ETENIL]-N-METILBENZENAMINA; NATIONAL AUTHORISATION NUMBER: EU/1/12/805; DATE OF NATIONAL AUTHORISATION: 20130114; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/12/805; DATE OF FIRST AUTHORISATION IN EEA: 20130114 |
| 1999109 | C20130016 00076 | Estonia | Start Trial | PRODUCT NAME: FLORBETAPIIR (18F);REG NO/DATE: K(2013)137 (LOPLIK) 14.01.2013 |
| 1999109 | 481 | Finland | Start Trial | |
| 1999109 | 34/2013 | Austria | Start Trial | PRODUCT NAME: FLORBETAPIR (18F); REGISTRATION NO/DATE: EU/1/12/805 20130114 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.